Recent studies have shown that hsa-miR-130b-3p acts as a tumor suppressor, inhibiting cancer angiogenesis by specifically targeting tumor necrosis factor-α (TNF-α), thereby suppressing the nuclear factor-κB/vascular endothelial growth factor-A (NF-κB/VEGFA) signaling pathway [66]. Here, TNF is linked to neoplasm.